A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
Sven J. van der Lee(Amsterdam Neuroscience), Estrella Morenas‐Rodríguez(Universitat Autònoma de Barcelona), Netherlands Brain Bank(Mayo Clinic in Florida), Juan Fortea(Hospital de Sant Pau), Alberto Lleó(Hospital de Sant Pau), Manuel A. Friese(Universität Hamburg), Jonas Mengel‐From(University of Southern Denmark), Kaj Blennow(Sahlgrenska University Hospital), Erik B. van den Akker(Leiden University Medical Center), Itziar de Rojas(Instituto de Salud Carlos III), Bernard Jeune(University of Southern Denmark), Adelina Orellana(Universitat Internacional de Catalunya), Jeanne E. Savage(Amsterdam Neuroscience), Michael J. Keogh(University of Cambridge), Najada Stringa(Amsterdam University Medical Centers), Luca Kleineidam(University of Bonn), Michael Wagner(University of Bonn), Iris E. Jansen(Amsterdam Neuroscience), Anna Zettergren(University of Gothenburg), Ignacio Illán‐Gala(Universitat Autònoma de Barcelona), Martin Scherer(Universität Hamburg), Marianne Nygaard(University of Southern Denmark), Ingmar Skoog(Sahlgrenska University Hospital), Carmen Lage(University of Oxford), Steffi G. Riedel‐Heller(Leipzig University), Cornelis Blauwendraat(National Institute of Neurological Disorders and Stroke), Till F. M. Andlauer(TUM Klinikum), Florian Then Bergh(Leipzig University), Christopher M. Morris(NIHR Newcastle Biomedical Research Centre), Henrik Zetterberg(University of Wisconsin–Madison), Javier Simón‐Sánchez(Amsterdam UMC Location Vrije Universiteit Amsterdam), Miren Zulaica(Biomedical Research Networking Center on Neurodegenerative Diseases), Mónica Díez-Fairén(University Hospital Mútua de Terrassa), Nina Beker(Amsterdam Neuroscience), Sonia Moreno–Grau(Galena Biopharma (United States)), Wei Wei(University of Cambridge), Xue Wang(Qiqihar University), Olga Pletnikova(Johns Hopkins University), Niccoló Tesi(Amsterdam UMC Location University of Amsterdam), Begoña Indakoetxea(Biogipuzkoa Health Research Institute), Jason Chen(University of California, Los Angeles), Kristel R. van Eijk(Utrecht University), Minerva M. Carrasquillo(Jacksonville College), Isabel Hernández(Universitat Internacional de Catalunya), Olivia J. Conway(Leiden University Medical Center), The GIFT (Genetic Investigation in Frontotemporal Dementia and Alzheimer’s Disease) Study Group(University of Bonn), EADB (Alzheimer Disease European DNA biobank)(Mayo Clinic in Florida), Lyduine E. Collij(Lund University), RiMod-FTD (Risk and Modifying factors in Fronto-Temporal Dementia)(Amsterdam Neuroscience), Marc Hulsman(Amsterdam University Medical Centers)
Cited by 132
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
|Nature Genetics|2019|3.3k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k
New insights into the genetic etiology of Alzheimer’s disease and related dementias
|Nature Genetics|2022|2.5k